Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Henryschein Dental Company (NQ: HSIC )

75.08 +1.31 (+1.78%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Henryschein Dental Company

< Previous 1 2 3 4 Next >
Peering Into Henry Schein's Recent Short Interest
Via Benzinga
Analyst Ratings For Henry Schein
Via Benzinga
Henry Schein Q3 Earnings: Sees Recovery From Cyber Incident, Says Dental Equipment Business Shows Stability In North America
Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises full-year EPS guidance upwards. 
Via Benzinga
Where Henry Schein Stands With Analysts
Via Benzinga
Forecasting The Future: 5 Analyst Projections For Henry Schein
Via Benzinga
HSIC Stock Earnings: Henry Schein Meets EPS, Misses Revenue for Q2 2024
HSIC stock results show that Henry Schein met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Dental Equipment Distributor Henry Schein Reports Mixed Q2 Earnings, Cuts Guidance And Warns Slower Recovery From Cyberattack
Henry Schein Q2 adjusted EPS fell 6.1% to $1.23, beating the $1.22 consensus. Sales grew 1% to $3.10 billion, missing the $3.27B forecast. The company announced a restructuring plan for $75-$100... 
Via Benzinga
Analyst Expectations For Henry Schein's Future
Via Benzinga
Breaking Down Henry Schein: 4 Analysts Share Their Views
Via Benzinga
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
You’ve Been Warned! 3 S&P 500 Stocks to Buy Now or Regret Forever.
The Magnificent Seven aren't the only game in town. These less discovered S&P 500 stocks to buy will deliver tremendous results going forward. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
NASDAQ:HSIC: good value for what you're paying.
HENRY SCHEIN INC (NASDAQ:HSIC) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
Looking Into Henry Schein's Recent Short Interest
Via Benzinga
Peering Into Henry Schein's Recent Short Interest
Via Benzinga
Looking Into Henry Schein's Recent Short Interest
Via Benzinga
Expert Outlook: Henry Schein Through The Eyes Of 7 Analysts
Via Benzinga
(HSIC) - Analyzing Henry Schein's Short Interest
Via Benzinga
5 Analysts Assess Henry Schein: What You Need To Know
Via Benzinga
Dental Supplies Distributor Henry Schein's Tech Segment Provides Some Stability In Challenging Macro Times: Analyst
Henry Schein reports Q1 adjusted EPS at $1.10, down 9% Y/Y, with sales at $3.17 billion, up 3.7%. Guidance projects 2024 sales growth at 8%-10%, reaffirming adjusted EPS guidance of $5.00-$5.16.... 
Via Benzinga
HSIC Stock Earnings: Henry Schein Beats EPS, Misses Revenue for Q1 2024
HSIC stock results show that Henry Schein beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
The analysis screened S&P 500 stocks that show an inverse correlation to Nvidia over a month and year period, following Nvidia's stock falling into correction territory for the second time this month. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cybersecurity Incident Casts Shadow On Henry Schein's Q4 Performance, Analysts Optimistic On Dental Sector
Henry Schein reports fourth quarter 2023 sales at $3.02 billion. Despite cybersecurity challenges, William Blair is optimistic. 
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Henry Schein Earnings Preview
Via Benzinga
Looking Into Henry Schein's Recent Short Interest
Via Benzinga
What 8 Analyst Ratings Have To Say About Henry Schein
Via Benzinga
What 5 Analyst Ratings Have To Say About Henry Schein
Via Benzinga
What Vitamins Did For Healthy Living, Stemtech Corporation (OTCQB: STEK) Says It Is Doing For Anti-Aging With Stem Cell Nutrition
Vitamins may not be a miracle cure, but combined with exercise and a healthy diet, they have the potential to greatly improve health and wellness. It’s no wonder vitamin supplements are a multi-billion... 
Via Benzinga
Behind Al Gore's $19 Billion Investment Firm and How He Made Millions in Apple Stock
Is Al Gore one of the best investors of the century? He should be in the conversation. 
Via The Motley Fool
These Analysts Slash Their Forecasts On Henry Schein After Q3 Results
Henry Schein Inc (NASDAQ: HSIC) posted downbeat sales results for its third quarter on Monday. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.